FAB-144

FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.

FAB-144
Legal status
Legal status
Identifiers
IUPAC name
  • 1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indazole
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC20H27FN2O
Molar mass330.447 g·mol−1
3D model (JSmol)
SMILES
  • FCCCCCN1N=C(C(C2C(C)(C)C2(C)C)=O)C3=C1C=CC=C3
InChI
  • InChI=1S/C20H27FN2O/c1-19(2)18(20(19,3)4)17(24)16-14-10-6-7-11-15(14)23(22-16)13-9-5-8-12-21/h6-7,10-11,18H,5,8-9,12-13H2,1-4H3
  • Key:LVJQJRUAYXVEGN-UHFFFAOYSA-N

Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.[2]

See also

References
  1. "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
  2. "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.